TOATE PRODUSELE SUNT STRICT NUMAI PENTRU CERCETARE. NU PENTRU CONSUMUL UMAN.

How to Read a COA and HPLC Report for Tirzepatide Lots

PeptideLab Editorial

PeptideLab Editorial

Echipa editorială

How to Read a COA and HPLC Report for Tirzepatide Lots

Research Use Only. This article supports laboratory purchasing decisions. It is not medical advice and does not describe human injection or compounding.

Grey-market peptide listings often show a pretty vial and a PDF with no method detail. For metabolic and endocrine research, the Certificate of Analysis (COA) and HPLC trace are where reproducibility lives or dies.

What a defensible COA should include

  • Product identity — INN or catalog name, batch/lot number, manufacture date
  • Purity method — HPLC with column type, gradient, and main-peak area percent
  • Identity confirmation — MS (expected MW) or peptide mapping for lipidated sequences
  • Storage — lyophilized, recommended lab storage temperature
  • RUO statement — explicit “not for human consumption or injection”

Red flags common in low-quality supply

SignalWhy it matters
COA re-used across unrelated batchesNo lot traceability
Purity claimed without chromatogramCannot audit integration
No identity test on GLP-1 analogsWrong lipidation or deletion sequences
“99%” with no method referenceMarketing, not QC

HPLC: what your analyst should check

  1. Main peak retention consistent with prior reference lots from the same supplier.
  2. Impurity profile — early-eluting deletion peptides and late aggregates.
  3. Peak shape — tailing can indicate degradation or column overload artifacts.

Tirzepatide-specific context

Tirzepatide is a dual GIP/GLP-1 agonist with non-natural residues and side-chain chemistry. Identity is not optional: a wrong conjugation or oxidized lot will shift potency in cell-based incretin assays and invalidate animal study arms.

Before you place a repeat order

Request the same method revision as your first qualified lot, and archive chromatograms with your ELN. Institutions increasingly ask for blinded third-party verification — plan for that in grant budgets.

For catalog material with batch COA on file, see our tirzepatide RUO listing and quality control overview.


    Chat with us